ConductScience.org, home

Comparison · NCT01857310-d04f675c

Folic Acid and Zinc Supplementation vs Placebo: Ectopic Pregnancy

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Folic Acid and Zinc Supplementation vs Placebo: Ectopic Pregnancy. Trial comparisons, record NCT01857310-d04f675c. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01857310-d04f675c

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.005060.002320.011wilson
Risk in group 20.004220.00180.00984wilson
Risk difference, group 1 minus group 20.000844-0.005410.00726newcombe hybrid score
Risk ratio, group 1 over group 21.20.3673.92log
Odds ratio, group 1 over group 21.20.3663.95log
Number needed to treat, for one more participant with the outcome on Folic Acid and Zinc Supplementation than on Placebo1,180from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Folic Acid and Zinc Supplementation5 mg folic acid and 30 mg elemental zinc, taken orally, daily for 6 months.~5 mg folic acid and 30 mg elemental zinc61,185OG000
Group 2PlaceboMatching placebo, taken orally daily for 6 months.~Placebo Comparator: Placebo51,185OG001

Outcome

Type
SECONDARY
Title
Ectopic Pregnancy
Description
Either visualization of no gestational sac in the uterus with a suspicious mass in the adnexa on ultrasound, an hCG level more than 1500 mIU/ml without visualization of an intrauterine gestational sac on ultrasound, or a slowly rising or plateauing serum hCG level without visualization of an intrauterine gestation on ultrasound.
Time frame
approximately 6.5 weeks gestation
Population

Source ClinicalTrials.gov

Trial

Title
Folic Acid and Zinc Supplementation Trial (FAZST)
NCT number
NCT01857310
Phases
NA
Conditions
Pregnancy, Live Birth, Spontaneous Abortion
Interventions
5 mg folic acid and 30 mg elemental zinc, Placebo Comparator: Placebo
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Results first posted
2020-11-19

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01857310-d04f675c